Sutinat 50 (Sunitinib Capsule) 50mg

Sutinat 50 is a 50mg capsule containing sunitinib, used for targeted cancer therapy. This oral medication helps manage certain types of tumors by inhibiting specific growth signals. Suitable for patients requiring precision oncology support. Shop sunitinib 50mg capsules online for convenience.

Strength

50mg

Manufacturer / TM Owner

Natco Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sutininb 50 is prescribed to treat advanced kidney cancer and gastrointestinal stromal tumors (GIST) when other treatments are ineffective. It works by blocking signals that promote tumor growth and blood vessel formation. Doctors may also use it for advanced pancreatic neuroendocrine tumors. This medication is part of targeted therapy approaches in oncology. Always follow a healthcare provider’s guidance for use.

Side Effects

Sutinat 50 may cause fatigue, nausea, or digestive discomfort as common effects. Some users report changes in taste or skin discoloration. These effects vary by individual and may lessen over time. Keeping a symptom diary can help track any changes during treatment.

Precautions & Warnings

Store Sutinat 50 capsules at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid crushing or opening capsules unless instructed. Use caution when handling to prevent exposure. Report any unusual symptoms to a healthcare professional promptly.

Avoid Interactions

Sutinat 50 may interact with strong CYP3A4 inhibitors or inducers, altering its effectiveness. Grapefruit products can affect how the body processes this medication. Discuss all current medications, including over-the-counter and herbal supplements, with your doctor. Alcohol use may increase side effects like dizziness.

References

Frequently Asked Questions

Sutinat 50 is used to treat advanced kidney cancer, gastrointestinal stromal tumors, and certain pancreatic neuroendocrine tumors.

Take Sutinat 50 exactly as prescribed by your doctor, usually once daily with or without food.

Common side effects include fatigue, nausea, digestive issues, and skin discoloration.

Sutinat 50 may be available for purchase through licensed online pharmacies with a valid prescription.

Yes, it may interact with CYP3A4 inhibitors, inducers, or grapefruit products; consult your doctor.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.